Pacira BioSciences（NASDAQ:PCRX）公布季度每股收益為 $0.91，較分析師一致預期的 $0.84 高出 8.33%。與去年同期的 $0.89 相比增長 2.25%。公司報告季度銷售額為 $1.8725 億，較分析師一致預期的 $1.8436 億高出 1.57%。相比去年同期的 $1.8124 億，銷售額增長了 3.32%。

以上內容來自Benzinga Earnings專欄，原文如下：

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.84 by 8.33 percent. This is a 2.25 percent increase over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $187.25 million which beat the analyst consensus estimate of $184.36 million by 1.57 percent. This is a 3.32 percent increase over sales of $181.24 million the same period last year.